signs Archives - Mediarabe

Coronavirus updates: Birx warns of ‘troubling signs’ in Northeast amid ‘very different’ spread of COVID-19

October 10, 2020

“What we did in the spring is not going to work in the fall,” Birx said.

Last Updated: October 9, 2020, 8:34 PM ET

A pandemic of the novel coronavirus has now killed more than 1 million people worldwide.

Over 36.7 million people across the globe have been diagnosed with COVID-19, the disease caused by the new respiratory virus, according to data compiled by the Center for Systems Science and Engineering at Johns Hopkins University. The criteria for diagnosis — through clinical means or a lab test — has varied from country-to-country. Still, the actual numbers are believed to be much higher due to testing shortages, many unreported cases and suspicions that some national governments are hiding or downplaying the scope of their outbreaks.

Since the first cases were detected in China in December, the virus has rapidly spread to every

U.S. signs agreement with AstraZeneca to develop, supply COVID-19 antibody treatment

October 10, 2020

| No Comments

| Health

(Reuters) – The U.S. government on Friday signed an agreement with AstraZeneca Plc <AZN.L> worth $486 million to develop and secure supplies of up to 100,000 doses of COVID-19 antibody treatment, a similar class of drugs that was used to treat President Donald Trump.

The U.S. health agency will provide the funding to AstraZeneca for two Phase 3 clinical trials under operation Warp Speed, which is aimed at speeding up treatments and vaccines for COVID-19.

One trial will evaluate the safety and efficacy of the experimental treatment to prevent infection for up to 12 months, in about 5,000 participants, while the second trial will evaluate post-exposure preventative and pre-emptive treatment in roughly 1,100 participants.

AstraZeneca said it plans to supply up to 100,000 doses starting towards the end of 2020 and the US Government can acquire up to an additional one million doses in 2021 under a separate agreement.

U.S. Signs Agreement With AstraZeneca to Develop, Supply COVID-19 Antibody Treatment | Top News

October 10, 2020

| No Comments

| Health

(Reuters) – The U.S. government on Friday signed an agreement with AstraZeneca Plc

worth $486 million to develop and secure supplies of up to 100,000 doses of COVID-19 antibody treatment, a similar class of drugs that was used to treat President Donald Trump.

The U.S. health agency will provide the funding to AstraZeneca for two Phase 3 clinical trials under operation Warp Speed, which is aimed at speeding up treatments and vaccines for COVID-19.

AstraZeneca said it plans to supply up to 100,000 doses starting towards the end of 2020 and the US Government can acquire up to an additional one million doses in 2021 under a separate agreement.

In a

New Zealand’s Ubiquitome signs NIH RADx contract

October 6, 2020

| No Comments

| Health Article

Its Liberty16 open system RT-PCR offers rapid, mobile testing for COVID

New Zealand-based Ubiquitome is ramping up production of its mobile, real-time (RT) PCR technology with funding from the United States’ National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative.

Ubiquitome is the only NZ private company to be accepted into the highly competitive RADx and to receive federal funding through the NIH in recent years.

As one of the first RADx-Tech contracts awarded outside the US, Ubiquitome will scale its Liberty16 mobile PCR technology to enable thousands of tests per day by the end of the year.

The Liberty16 will be targeted for use by rural and metropolitan hospitals and mobile labs to test for SARS-CoV-2 – the virus that causes COVID-19.

Ubiquitome’s device can detect virus in 16 samples in 40 minutes or less. It reports positive or negative results via its proprietary iPhone app.

Battery-operated,

Stocks recover on signs of Trump’s improving health

October 5, 2020

| No Comments

| Global Health

MILAN (Reuters) – Stocks and other risk assets rose on Monday as signs that Donald Trump’s health was improving brought relief to markets after the uncertainty of his COVID-19 infection sent investors rushing for safety last week.

The U.S. President, 74, was flown to a hospital for treatment on Friday, but his doctors said he had responded well and could return to the White House as soon as on Monday.

The MSCI world equity index .MIWD00000PUS, which tracks shares in 49 countries, was up 0.4% by 0812 GMT, supported by overnight gains across Asia and a positive start in Europe.

The pan-European STOXX 600 .STOXX rose 0.7%. S&P 500 futures EScv1 rose 0.5% and Nasdaq futures NQc1 0.8%, indicating a similarly strong start on Wall Street later.

Overhanging the relief rally, however, were concerns that Trump’s case could be more severe than public disclosures suggest, and that more restrictive

Concerning signs for Trump’s health despite word from White House doctor that president is doing ‘very well’

October 3, 2020

| No Comments

| Good Health

ASSOCIATED PRESS

a group of people wearing costumes: Dr. Sean Conley, physician to President Donald Trump, briefs reporters at Walter Reed National Military Medical Center in Bethesda, Md., on Saturday. Trump was admitted to the hospital after contracting the coronavirus.

© Associated Press
Dr. Sean Conley, physician to President Donald Trump, briefs reporters at Walter Reed National Military Medical Center in Bethesda, Md., on Saturday. Trump was admitted to the hospital after contracting the coronavirus.

President Donald Trump’s doctor insisted Saturday that he is doing “very well” as he is treated for COVID-19 at a military hospital. But Navy Commander Dr. Sean Conley and other doctors raised more questions than they answered at a briefing, leaving unclear whether the president has ever required supplemental oxygen.

Conley’s assessment was contradicted by an account provided by a person familiar with Trump’s condition, who said some of his vital signs over the past 24 hours were “very concerning” and that the next 48 hours will be critical in terms of his care. The person was not authorized to speak publicly and spoke to The Associated Press on condition of anonymity.

Signs America’s Opioid Epidemic Might Finally Be Waning | Health News

October 3, 2020

| No Comments

| Health News

By Robert Preidt, HealthDay Reporter

(HealthDay)

SATURDAY, Oct. 3, 2020 (HealthDay News) — Here’s some heartening news on the opioid painkillers front: Abuse of the prescription medicines in the United States fell by more than one-quarter between 2007 and 2018.

“Prior research has shown slight reductions in abuse rates, but our analysis shows we’re tracking statistically significant year-to-year declines in abuse, indicating that the decrease is not an anomaly and truly represents a trend in falling prescription drug abuse levels,” said study author Mario Moric, a biostatistician at Rush University Medical Center in Chicago.

He and his colleagues analyzed data from the National Survey on Drug Use and Health, an annual survey of about 70,000 Americans aged 12 and older who are asked about their use of tobacco, alcohol and drugs.

For the study, prescription opioid abuse was defined as use without the consent of a physician.

The percentage of

Halo Signs Definitive Agreement to Acquire Canmart

October 3, 2020

| No Comments

| Health News

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated September 16, 2020 to its short form base shelf prospectus dated September 2, 2020.

Not for Distribution to U.S. Newswire Servicers or For Dissemination in the United States

All figures in CAD unless stated otherwise

Halo Labs Inc. (“Halo” or the “Company“) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) has entered into a definitive share purchase agreement, (the “Share Purchase Agreement“) pursuant to which the Company, in exchange for up to 72,463,768 common shares of Halo (“Halo Shares“), will acquire all of the issued and outstanding shares of Canmart Ltd. (“Canmart“), a licensed importer and distributor of cannabis-based products for medicinal use (“CBPMs“) in the United Kingdom (“UK“) (the “Acquisition“). Issuance of certain Halo Shares will be subject

Chris Wallace, who moderated Tuesday debate, said Trump showed no signs of ill health

October 2, 2020

| No Comments

| Good Health

Jason Abbruzzese

5h ago / 12:26 PM UTC

Chris Wallace, the moderator of the first presidential debate on Tuesday, said in an interview on Friday that Trump showed no signs of illness at the event.

But he also noted that Trump’s family members present at the debate did not abide by the mask mandates put in place by the Cleveland Clinic.

“The interesting thing was that the Cleveland Clinic said that everybody in the hall with the exception of the president the vice president and myself had to wear a mask,” Wallace said.

Trump’s group wore masks as they entered the hall but took them off when they sat down. According to NBC News reporters who attended the debate, a doctor from the Cleveland Clinic tried to offer some of the group masks but was waived away.

Wallace added that Trump’s positive test will recenter the focus of the election

Trump Signs Medicare Loan Relief Bill Delaying Repayments

October 1, 2020

| No Comments

| Health

President Trump on Thursday morning signed a bill to keep the federal government running through December 11. This “continuing resolution” (CR), which was approved by the Senate Wednesday on an 84-10 vote, according to The New York Times, includes provisions to delay repayment by physicians of pandemic-related Medicare loans and to reduce the loans’ interest rate.

In an earlier news release, the American Medical Association (AMA) reported that Congress and the White House had agreed to include the provisions on Medicare loans in the CR.

Under the Medicare Accelerated and Advance Payments (AAP) program, the Centers for Medicare & Medicaid Services (CMS) advanced money to physicians who were financially impacted by the pandemic. The program, created in March, was suspended in late April.

Physicians who received the Medicare loans were supposed to start paying them back 120 days after they were made. CMS planned to recoup the advances by offsetting

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30